ArticleFrontiers in oncology2023

Long-lasting benefit on multimodal treatment combining osimertinib and stereotaxic radiotherapy for metastatic non-small cell lung cancer with the EGFR exon 20 insertion 773-774 HVdelinsLM: a case report.

Aurélie Louvet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.